Ravi Krishnamoorthy

Title: Innovations of Ravi Krishnamoorthy

Introduction

Ravi Krishnamoorthy is an accomplished inventor based in Guilderland, NY (US). He holds a total of four patents, showcasing his significant contributions to the field of pharmaceutical compounds. His work primarily focuses on developing innovative solutions for treating immune disorders.

Latest Patents

Among his latest patents are the pyridone and aza-pyridone compounds and methods of use. These compounds, represented by Formula I, include stereoisomers, tautomers, and pharmaceutically acceptable salts. They are particularly useful for inhibiting Btk kinase, which plays a crucial role in immune responses. The methods disclosed in his patents detail the use of these compounds for in vitro, in situ, and in vivo diagnosis and treatment of disorders related to Btk kinase in mammalian cells.

Career Highlights

Ravi has worked with notable companies such as Gilead Connecticut, Inc. and Genentech, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in medical treatments.

Collaborations

Throughout his career, Ravi has collaborated with esteemed colleagues, including Antonio J M Barbosa and Peter A Blomgren. These partnerships have further enriched his research and development efforts.

Conclusion

Ravi Krishnamoorthy's innovative work in the field of pharmaceutical compounds has made a lasting impact on the treatment of immune disorders. His patents reflect a commitment to advancing medical science and improving patient outcomes.